3rd Circ. Won't Rethink Provigil Antitrust Decision
By Eric Kroh ( October 31, 2016, 3:03 PM EDT) -- The Third Circuit on Monday declined to reconsider a September ruling vacating a decision certifying purchasers that say Mylan Inc. and Ranbaxy Laboratories Ltd. inked pay-for-delay deals with Provigil maker Cephalon Inc....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.